References
- Simonetti RG, Camma C, Fiorello F, Politi F, D'amico G, Pagliaro L. Hepatocellular carcinoma a worldwide problem and the major risk factors. Dig Dis Sci. 1991;36:962-972. https://doi.org/10.1007/BF01297149
- Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000;16:168-174. https://doi.org/10.1016/S0168-9525(99)01971-X
- Park HJ, Yu E, Shim YH. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma. Cancer Lett. 2006;233:271-278. https://doi.org/10.1016/j.canlet.2005.03.017
- Oh B-K, Kim H, Park HJ, Shim YE, Choi J, Park C, et al. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Int J Mol Med. 2007;20:65-73. https://doi.org/10.3892/ijmm.20.1.65
- Rovertson KD. DNA methylation, methyltransferases, and cancer. Oncogene. 2001;20:3139-3155. https://doi.org/10.1038/sj/onc/1204341
- Bestor TH. Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain. EMBO J. 1992;11:2611-2617. https://doi.org/10.1002/j.1460-2075.1992.tb05326.x
- Schneider-Stock R, Ocker M. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors. IDrugs. 2007;10:557-561.
- Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247-257. https://doi.org/10.1016/S0092-8674(00)81656-6
- Vertino PM, Yen R-W C, Gao J, Baylin SB. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (Cytosine-5-)-Methyltransferase. Mol Cell Biol. 1996;16:4555-4565. https://doi.org/10.1128/mcb.16.8.4555
- Rhee I, Jair KW, Yen R-W C, Lengauer C, Herman JG, Kinzler KW, et al. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature. 2000;404:1003-1007. https://doi.org/10.1038/35010000
- Tate PH, Bird AP. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev. 1993;3:226-231. https://doi.org/10.1016/0959-437x(93)90027-m
- Alan Wang Y, Kamarova Y, Shen KC, Jiang Z, Hahn MJ, Wang Y, et al. DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression. Cancer Biol Ther. 2005;4:1138-1143. https://doi.org/10.4161/cbt.4.10.2073
- Varela M, Real MI, Burrel M, Fomer A, Sala M, Brunet M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007;46:474-481. https://doi.org/10.1016/j.jhep.2006.10.020
- Duffy A, Greten T. Developing better treatments in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2014;4:551-560. https://doi.org/10.1586/egh.10.58
- Engel N, Oppermann C, Falodun A, Kragl U. Proliferative effects of five traditional Nigerian medicinal plant extracts on human breast and bone cancer cell lines. J Ethnopharmacol. 2011;137:1003-1010. https://doi.org/10.1016/j.jep.2011.07.023
- Wu HL, Chuang TY, Diamond MP, Azziz R, Chen Y-H. Berberine inhibits the proliferation of human uterine leiomyoma cells. Fertil Steril. 2015;103:1098-1106. https://doi.org/10.1016/j.fertnstert.2015.01.010
- Xu J, Long Y, Ni L, Yuan X, Yu N, Wu R, Tao J, Zhang Y. Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis. BMC Cancer. 2019;19:589. https://doi.org/10.1186/s12885-019-5791-1
- Guo P, Cai C, Wu X, Fan X, Huang W, Zhou J, Wu Q, Huang Y, Zhao W, Zhang F, Wang Q, Zhang Y, Fang J. An insight into the molecular mechanism of berberine towards multiple cancer types through systems pharmacology. Front Pharmacol. 2019;10:857. https://doi.org/10.3389/fphar.2019.00857
-
Kim S, Choi JH, Kim JB, Nam SJ, Yang J-H, Kim J-H, et al. Berberine Suppresses TNF-
$\alpha$ -induced MMP-9 and Cell Invasion through Inhibition of AP-1 Activity in MDA-MB-231 Human Breast Cancer Cells. Molecules. 2008;13:2975-2985. https://doi.org/10.3390/molecules13122975 - Peng P-L, Hsieh Y-S, Wang C-J, Hsu J-L, Chou F-P. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol Appl Pharmacol. 2006;214:8-15. https://doi.org/10.1016/j.taap.2005.11.010
- Gupta SC, Kim JH, Prasad S, Aggarwal BB. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010;29:405-434. https://doi.org/10.1007/s10555-010-9235-2
- Qing Y, Hu H, Liu Y, Feng T, Meng W, Jiang L, et al. Berberine induces apoptosis in human multiple myeloma cell line U266 through hypomethylation of p53 promoter. Cell Biol Int. 2013;38:563-570. https://doi.org/10.1002/cbin.10206
- Zhang Y, C,hang X, Song X, Chen C, Chen H, Lu Z, et al. Berberine reverses abnormal expression of L-type pyruvate kinase by DNA demethylation and histone acetylation in the livers of the non-alcoholic fatty disease rat. Int J Clin Exp Med. 2015;8:7535-7543.
- Puisieux A, Galvin K, Troalen F, Bressac B, Marcais C, Galun E, et al. Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEB. 1993;7:1407-1413. https://doi.org/10.1096/fasebj.7.14.8224613
- Levine AJ. p53, the cellular gatekeeper review for growth and division. Cell. 1997;88:323-331. https://doi.org/10.1016/s0092-8674(00)81871-1
- Wang H, Li K, Ma L, Wu S, Hu J, Yan H, et al. Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy. Virol. 2017;14:2. https://doi.org/10.1186/s12985-016-0674-4
- Hwang JM, Wang CJ, Chou FP, Tseng TH, Hsieh YS, Lin WL, et al. Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver. Arch Toxicol. 2002;76:664-670. https://doi.org/10.1007/s00204-002-0351-9
- Yokozawa T, Ishida A, Kashiwada Y, Cho EJ, Kim HY, Ikeshiro Y. Coptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components. J Pharm Pharmacol. 2004;56:547-556. https://doi.org/10.1211/0022357023024
- Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. Ethnopharmacol. 1999;66: 227-233. https://doi.org/10.1016/s0378-8741(98)00162-7
- Iizuka N, Miyamoto K, Okita K, Tangoku A, Hayashi H, Yosino S, et al. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett. 2000;148:19-25. https://doi.org/10.1016/s0304-3835(99)00264-5
- Wang N, Feng Y, Zhu M, Tsang C-H, Man K, Tong Y, et al. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. . J Cell Biochem. 2010;111:1426-1436. https://doi.org/10.1002/jcb.22869
- Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, et al. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Mol Carcinog. 2002;35:85-92. https://doi.org/10.1002/mc.10076
- Lambert MP, Paliwal A, Vaissiere T, Chemin I, Zoulim F, Tommasino M, et al. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol. 2011;54:705-715. https://doi.org/10.1016/j.jhep.2010.07.027
- Yeo W, Wong N, Wong WL, Lai PB.S, Zhong S, Johnson PJ. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma. Liver Int. 2005;25:266-272. https://doi.org/10.1111/j.1478-3231.2005.01084.x
- Hu L, Chen G, Yu H, Qiu X. Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma. Hepatol Int. 2010;4:423-432. https://doi.org/10.1007/s12072-010-9164-8
- Liu Q, Xu X, Zhao M, Wei Z, Li X, Zhang X, et al. Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway. Mol Cancer Ther. 2014;14:355-363. https://doi.org/10.1158/1535-7163.mct-14-0634
- Kim HS, Kim M, Kim EJ, Yang Y, Lee MS, Lim JS. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem Pharmacol. 2012;83:385-394. https://doi.org/10.1016/j.bcp.2011.11.008
- Friedman SL, Shaulian E, Littlewood T, Resnitzky D, Oren M. Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells. Oncogene. 1997;15:63-70. https://doi.org/10.1038/sj.onc.1201149
- Esteve P-O, Chin HG, Pradhan S. Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc Natl Acad Sci USA. 2005;102:1000-1005. https://doi.org/10.1073/pnas.0407729102
Cited by
- Nanotechnology-Based Strategies for Berberine Delivery System in Cancer Treatment: Pulling Strings to Keep Berberine in Power vol.7, 2020, https://doi.org/10.3389/fmolb.2020.624494